Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Briacell Therapeutics Corp T.BCT

Alternate Symbol(s):  BCTX | BCTXW

BriaCell Therapeutics Corp. is a clinical-stage biotechnology company that develops novel immunotherapies to transform cancer care. Bria-IMT, its Phase 3 lead candidate, is a patented, off-the-shelf, cell-based, targeted immunotherapy that activates the patient’s immune system to specifically kill cancer cells without harming other cells. The Company is advancing its Bria-IMT targeted... see more

TSX:BCT - Post Discussion

Briacell Therapeutics Corp > BCTX To Quickly Regain $8/share
View:
Post by LondonInvest on Apr 29, 2022 5:52am

BCTX To Quickly Regain $8/share

Short-tem, BCTX should quickly regain $8/share to keep the 50-DMA rising and above the 200-DMA.  Very bullish here.  Short-term this will add confidence the recent decline has put in another firm support at a higher low.  Chart looks good.  Long-term you will be hard-pressed to distinguish between $6.69 or $8 on a chart looking back.  Thought I would share my short-term views, but long-term is where the money is.
Comment by LondonInvest on May 12, 2022 2:52pm
Well, that did not turn out at all how I imagined it.  I was able to add at these low levels today.  Still think there is really good returns possible here.  I am a holder of company.  Fast Track Designation is not just granted to anyone.  We will see where we are in a year.  These levels are insane.  Essentially at cash on hand levels now.  I think small ...more  
Comment by dragshot on Jul 01, 2022 7:32am
I think you're on the right track here with the 50 and 200DMA.  We now have a situation with both a falling 50 and 200.  This is a red flag for me.  I would have sold back in April when the 50 was starting to turn flat and price crashed thru the 200. Now we're in "no man's land" and currently heading into what may very well end up being shorting territory.  ...more  
Comment by LondonInvest on Jul 06, 2022 11:05am
I agree, but the 200-DMA is only a slight decline and I like how BCTX is tugging on the 50-DMA pulling it back up.  Chart looks like it has a ton of potential on weekly chart.  Could have real legs.  I am expecting the whole biotech sector to start getting bid up in size.  We will see.  I have my position and it is quite news dependent.  Day to day doesn't matter ...more  
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities